-
JAMA Netw Open: A randomized clinical trial of losartan in hospitalized patients with COVID-19 lung injury
Time of Update: 2022-05-16
This randomized clinical trial found that 7 days after initiation of oral losartan treatment in hospitalized patients with COVID-19 and acute lung injury, the PaO2/FiO2 ratio did not improve .
-
Lancet Neurol: Losartan is not yet effective in improving brain atrophy in patients with clinically diagnosed Alzheimer's disease
Time of Update: 2021-11-13
Recently, researchers have investigated whether the angiotensin II receptor antagonist losartan can reduce brain volume loss in patients with a clinical diagnosis of mild Alzheimer’s disease compared with placebo , thereby as a disease progression Metric .
-
Lancet Sub-Journal: Safety and Effectiveness Analysis of AngII Receptor Antagonist Losartan in Reducing Brain Atrophy in Alzheimer's Disease
Time of Update: 2021-11-13
1016/S1474-4422 (21)00263-5Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial.
-
What are the main uses of Azilsartan medoxomil potassium salt
Time of Update: 2021-09-05
Go to the hospital regularly to measure high blood pressure to avoid the symptoms of low pressure during the period of taking medicines .
-
What are the pharmacological effects of Azilsartan
Time of Update: 2021-09-05
For the occurrence of three high symptoms, you can take this medicine once a day, one tablet each time.
-
Yangtze River's antihypertensive drug "Azilsartan Tablets" is about to be approved, the second domestic manufacturer
Time of Update: 2021-08-26
for the third-class generic drug "Azisartan Tablets" of Yangtze River Pharmaceutical was changed to under review, which is expected to be approved in the near future . At present, only Hengrui's first copy
-
Hengrui Medicine's "Azilsartan Tablets" will be approved soon
Time of Update: 2021-06-05
under the name "Azilva". The company's 2016 annual report shows that Azilva and its series of products will help the company lead the Japanese pharmaceutical market in 2016-2018. Analysts believe that sales
-
[drug Kajun] drug review trends: the first class of new drug, losartan, imported patozumab
Time of Update: 2019-08-26
Highlights: 1
Application for listing of class 1 new drug losartan "issued" 2
The first domestic imitation of quetiapine fumarate sustained-release tablets
-
Global phase III clinical study of losartan confirms its cardiovascular safety
Time of Update: 2019-05-17
The results of mace and mace + analysis showed that rosaseta showed better safety than afayipoten in the treatment of anemia of patients with initial unstable dialysis.
-
$1.2 billion market! Haizheng losartan potassium tablets approved by FDA
Time of Update: 2019-04-11
On April 10, Zhejiang Haizheng Pharmaceutical Co., Ltd
issued a notice that its holding subsidiary Haizheng Pharmaceutical (Hangzhou) Co., Ltd
(hereinafter
-
It is found that losartan, a high blood pressure drug, may improve the effectiveness of chemotherapy drugs for ovarian cancer
Time of Update: 2019-01-17
Recently, a new study from the research team of Massachusetts General Hospital (MGH) found that losartan, a high blood pressure drug ( targeting the Angiotension signaling pathway, may improve the effectiveness of chemotherapy drugs used to treat ovarian cancer.
-
[Medicine] after the Valsartan toxin gate, the Huahai losartan potassium API was questioned again
Time of Update: 2018-11-13
On November 6, the general office of Shaanxi provincial Party committee and the general office of Shaanxi provincial government issued new policies to promote the reform of drug
-
Huahai issued two consecutive announcements to clarify that the NDEA content of losartan potassium recalled by Sandoz did not exceed the standard!
Time of Update: 2018-11-12
According to the announcement, Huahai has tested more than 500 batches of samples produced by the company from 2016 to 2018 by using the validated GC-MS analysis and detection method, and the content is within the acceptable limit standard.
-
of alisentan and azilsartan, and the import of selexipag and maxitetan are worth looking forward to!
Time of Update: 2018-02-02
Based on the registration and acceptance database of yaozhi.com, from the perspective of pharmacology, we analyzed the application and registration of anti-tumor drugs and diabetes
-
What is the difference between telmisartan and losartan in efficacy?
Time of Update: 2017-03-31
[China Pharmaceutical network health care] telmisartan and losartan are both used to treat essential hypertension.
Telmisartan and losartan are both used to treat essential hypertension.
-
Case study on the substitution of Eheng for Losartan
Time of Update: 2016-07-04
Source: emeda 2016-7-5 research brief this study demonstrates the substitutability of domestic innovative drugs for imported drugs from clinical application, pharmacoeconomics
